Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Alberti

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Journal of Hepatology|May 26, 2004
Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed?Alfredo Alberti
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Impact of a sustained virological response on the long-term outcome of hepatitis CAlfredo Alberti
Hepatology (Baltimore, Md.)|June 28, 2003
Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?Alfredo Alberti
Journal of Hepatology|January 25, 2005
Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levelsAlfredo Alberti
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?Alfredo Alberti
Journal of Hepatology|February 20, 2003
Management of hepatitis CAlfredo Alberti, Luisa Benvegnù
World Journal of Gastroenterology|June 15, 2006
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsyGiada Sebastiani, Alfredo Alberti
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2011
HBV therapy: guidelines and open issuesAlfredo Alberti, Nicola Caporaso
Journal of Hepatology|March 4, 2008
Implementing non-invasive markers for liver fibrosis in clinical practiceGiada Sebastiani, Alfredo Alberti
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2017
Increased incidence of liver cancer after successful DAA treatment of chronic hepatitis C: Fact or fiction?Alfredo Alberti, Sara Piovesan
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Journal of Hepatology|May 26, 2004
Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed?Alfredo Alberti
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Impact of a sustained virological response on the long-term outcome of hepatitis CAlfredo Alberti
Hepatology (Baltimore, Md.)|June 28, 2003
Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?Alfredo Alberti
Journal of Hepatology|January 25, 2005
Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levelsAlfredo Alberti
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?Alfredo Alberti
Journal of Hepatology|February 20, 2003
Management of hepatitis CAlfredo Alberti, Luisa Benvegnù
World Journal of Gastroenterology|June 15, 2006
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsyGiada Sebastiani, Alfredo Alberti
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2011
HBV therapy: guidelines and open issuesAlfredo Alberti, Nicola Caporaso
Journal of Hepatology|March 4, 2008
Implementing non-invasive markers for liver fibrosis in clinical practiceGiada Sebastiani, Alfredo Alberti
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2017
Increased incidence of liver cancer after successful DAA treatment of chronic hepatitis C: Fact or fiction?Alfredo Alberti, Sara Piovesan
Pageof 8